Literature DB >> 15564337

Insulin alone increases hypothalamo-pituitary-adrenal activity, and diabetes lowers peak stress responses.

Owen Chan1, Karen Inouye, Eitan Akirav, Edward Park, Michael C Riddell, Mladen Vranic, Stephen G Matthews.   

Abstract

Diabetes is associated with increased basal hypothalamo-pituitary-adrenal (HPA) activity and impaired stress responsiveness. Previously, we demonstrated that the HPA response to hypoglycemia is significantly impaired in diabetic rats. In this study our goals were to 1) differentiate between the effects of hyperinsulinemia and those of hypoglycemia per se, and 2) establish whether diabetes lowers peak stress responses. Normal and streptozotocin-diabetic rats were subjected to hyperinsulinemic-euglycemic glucose clamps to evaluate central and peripheral responses. These were compared with peak ACTH and corticosterone responses to restraint and hypoglycemia. Hyperinsulinemia increased CRH and vasopressin mRNA, and plasma ACTH and corticosterone in normal and diabetic rats. In normal animals, insulin-induced activation of ACTH and corticosterone was lower than the responses during either restraint or hypoglycemia. In contrast, ACTH and corticosterone activation in diabetic rats was similar with all three stressors. Pituitary-adrenal axis activation in diabetic animals was also much lower compared with that in normal controls. The response to hyperinsulinemia (euglycemia) was associated with increases in glucocorticoid receptor mRNA in the anterior pituitary and paraventricular nucleus. Hippocampal mineralocorticoid receptor mRNA expression was increased in normal, but not in diabetic, animals. We speculate that the ability to appropriately match the HPA response to the potency of a stressor is related to the ability to alter hippocampal mineralocorticoid receptor expression. In diabetes, this ability is impaired; hence, maximal HPA activation is greatly diminished. This is a novel observation that may have important implications in the treatment of impaired counterregulatory mechanisms in human diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564337     DOI: 10.1210/en.2004-0607

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  A Fall in plasma free fatty acid (FFA) level activates the hypothalamic-pituitary-adrenal axis independent of plasma glucose: evidence for brain sensing of circulating FFA.

Authors:  Young Taek Oh; Ki-Sook Oh; Insug Kang; Jang H Youn
Journal:  Endocrinology       Date:  2012-06-05       Impact factor: 4.736

2.  Metabolic Effect of the Hepatic Branch of the Vagal Nerve in One-Anastomosis Gastric Bypass (OAGB).

Authors:  Jaime Ruiz-Tovar; Carolina Llavero
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

3.  Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial.

Authors:  A Hamidovic; M Khafaja; V Brandon; J Anderson; G Ray; A M Allan; M R Burge
Journal:  Mol Psychiatry       Date:  2017-02-28       Impact factor: 15.992

4.  MAP kinases couple hindbrain-derived catecholamine signals to hypothalamic adrenocortical control mechanisms during glycemia-related challenges.

Authors:  Arshad M Khan; Kimberly L Kaminski; Graciela Sanchez-Watts; Todd A Ponzio; J Brent Kuzmiski; Jaideep S Bains; Alan G Watts
Journal:  J Neurosci       Date:  2011-12-14       Impact factor: 6.167

Review 5.  Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Authors:  Richa Tyagi; Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Pharmacol Rep       Date:  2022-09-23       Impact factor: 3.919

6.  Levels of maternal serum corticotropin-releasing hormone (CRH) at midpregnancy in relation to maternal characteristics.

Authors:  Yumin Chen; Claudia Holzman; Hwan Chung; Patricia Senagore; Nicole M Talge; Theresa Siler-Khodr
Journal:  Psychoneuroendocrinology       Date:  2009-12-16       Impact factor: 4.905

7.  Psychoneuroimmune implications of type 2 diabetes: redux.

Authors:  Jason C O'Connor; Daniel R Johnson; Gregory G Freund
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

8.  Glucocorticoid receptor changes associate with age in the paraventricular nucleus of type II diabetic rat model.

Authors:  Sun Shin Yi; In Koo Hwang; Myung Sun Chun; Yo Na Kim; Il Yong Kim; In Se Lee; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2008-08-29       Impact factor: 3.996

9.  Corticotropic axis drive of overnight cortisol secretion is suppressed in adolescents and young adults with type 1 diabetes mellitus.

Authors:  Animesh N Sharma; Jean Wigham; Johannes D Veldhuis
Journal:  Pediatr Diabetes       Date:  2013-12-18       Impact factor: 4.866

Review 10.  Intranasal Insulin: a Treatment Strategy for Addiction.

Authors:  Bhavani Kashyap; Leah R Hanson; William H Frey Ii
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.